GlaxoSmithKline Facility: Worthing

Bryden Wood were appointed by GSK to deliver integrated design services for a major new upgrade to an existing manufacturing facility in Worthing, UK. The project aimed to deliver regulatory compliance, revenue maintenance and improved process flows.

Bryden Wood delivered an integrated concept study incorporating architectural, structural, civil and MEP engineering. The project involved extensive engagement with GSK stakeholders. Bryden Wood rationalised the existing facility design to create a more streamlined production process focused on key process “islands
of manufacture” to reduce batch manufacturing complexity.